Interstitial inflammatory lesions of the pulmonary allograft: A retrospective analysis of 2697 transbronchial biopsies

Transplantation

Volumn 86, Issue 6, 2008, Pages 811-819

  Burton, Christopher M ^a   Iversen, Martin ^a   Carlsen, Jørn ^a   Andersen, Claus B ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Acute cellular rejection; Bronchiolitis obliterans; Bronchiolitis obliterans organizing pneumonia; Diffuse alveolar damage; Fibrosis; Interstitial pneumonitis; Lung transplant; Lymphocytic bronchiolitis; Primary graft dysfunction; Surveillance bronchoscopy

Indexed keywords

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LUNG LESION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; BIOPSY; BRONCHOSCOPY; BRONCHUS; CLASSIFICATION; HEART LUNG TRANSPLANTATION; INFLAMMATION; LUNG ALVEOLUS; LUNG DISEASE; LUNG LAVAGE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

BIOPSY; BRONCHI; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; INCIDENCE; INFLAMMATION; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES;

EID: 56049103563     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181852f02     Document Type: Article

References (48)

1. Glanville AR. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med 2006; 27: 480.
2. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunctioninlung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713.
3. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group. J Heart Lung Transplant 1996; 15(1 pt1): 1.
4. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1995 working formulation for the standardisation of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229.
5. Fisher AJ, WardleJ,Dark JH,et al. Non-immune acute graft injury after lung transplantation and the riskofsubsequent bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2002; 21: 1206.
6. Chaparro C, Chamberlain D, Maurer J, et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest 1996; 110: 1150.
7. Hopkins PM, Aboyoun CL, Chhajed PN, et al. Prospective analysis of 1,235 transbronchial lung biopsies inlung transplant recipients. J Heart Lung Transplant 2002; 21: 1062.
8. Pomerance A, Madden B, Burke MM, et al. Transbronchial biopsy in heart and lung transplantation: Clinicopathologic correlations. J Heart Lung Transplant 1995; 14: 761.
9. Calabrese F, Giacometti C, Rea F, et al. Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation. Transplantation 2002; 74: 1643.
10. Burton CM, Milman N, Carlsen J, et al. The Copenhagen national lung transplant group: Survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 2005; 24: 1834.
11. Burton CM, Kristensen P, Lutzhoft R, et al. Cytomegalovirus infection in lung transplant patients: The role of prophylaxis and recipient-donor serotype matching. Scand J Infect Dis 2006; 38: 281.
12. Burton CM, Andersen CB, Jensen AS, et al. The incidence of acute cellular rejection after lung transplantation: A comparative study of anti-thymocyte globulin and daclizumab. J Heart Lung Transplant 2006; 25: 638.
13. Tazelaar HD, Nilsson FN, RinaldiM, et al. The sensitivity oftransbron-chial biopsy for the diagnosis of acute lung rejection. J Thorac Cardio-vasc Surg 1993; 105: 674.
14. Travis WD, Colby TV, Koss MN, et al. Non-neoplastic disorders of the lower respiratory tract. Washington DC, American Registry of Pathology and Armed Forces Institute of Pathology 2002.
15. Husain AN, Siddiqui MT, Montoya A, et al. Post-lung transplant biopsies: An 8-year Loyola experience. Mod Pathol 1996; 9: 126.
16. Aboyoun CL, Tamm M, Chhajed PN, et al. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med 2001; 164: 460.
17. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297.
18. Sharples LD, McNeil K, Stewart S, et al. Risk factors for bronchiolitis obliterans: A systematic review of recent publications. J Heart Lung Transplant 2002; 21: 271.
19. Burton CM, Iversen M, Scheike T, et al. Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: A retrospective analysis of 2697 transbronchial biopsies. Transplantation 2008; 85: 547.
20. Gammie JS, Stukus DR, Pham SM, et al. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg 1999; 68: 2015.
21. Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: Definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant 2005; 24: 1454.
22. Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51.
23. Burton CM, Iversen M, Milman N, et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 2007; 31: 75.
24. Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007; 175: 507.
25. Schlesinger C, Koss MN. The organizing pneumonias: An update and review. Curr Opin Pulm Med 2005; 11: 422.
26. DeAngelo AJ, Ouellette D. Bronchiolitis obliterans organizing pneumonia in an orthotopic liver transplant patient. Transplantation 2002; 73: 544.
27. Thirman MJ, Devine SM, O'Toole K, et al. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 307.
28. Verberckmoes R, Verbeken E, Verschakelen J, et al. BOOP (bronchi-olitis obliterans organizing pneumonia) after renal transplantation. Nephrol Dial Transplant 1996; 11: 1862.
29. Chhajed PN, Dickenmann M, Bubendorf L, et al. Patterns of pulmonary complications associated with sirolimus. Respiration 2006; 73: 367.
30. Kleindienst R, Fend F, Prior C, et al. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus. Clin Transplant 1999; 13(1 Pt 1): 65.
31. Benden C, Aurora P, Burch M, et al. Monitoring of Epstein-Barr viral load inpediatric heart and lung transplant recipients byreal-time poly-merase chain reaction. J Heart Lung Transplant 2005; 24: 2103.
32. Bakker NA, Verschuuren EA, Erasmus ME, et al. Epstein-Barr virusDNA load monitoring late after lung transplantation: A surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation 2007; 83: 433.
33. Balthesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67: 5360.
34. Weinberg A, Hodges TN, Li S, et al. Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol 2000; 38: 768.
35. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: Incidence and prognosis. EurJ Clin Microbiol Infect Dis 2007; 26: 879.
36. Faul JL, Akindipe OA, Berry GJ, et al. Influenza pneumonia in a paedi-atric lung transplant recipient. Transpl Int 2000; 13: 79.
37. Glanville AR, Gencay M, TammM, et al. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant 2005; 24: 131.
38. Kuo E, Bharat A, Goers T, et al. Respiratory viral infection in oblitera-tive airway disease after orthotopic tracheal transplantation. Ann Tho-rac Surg 2006; 82: 1043.
39. Corrin B, Jagusch M, Dewar A, et al. Fine structural changes in idio-pathic pulmonary haemosiderosis. J Pathol 1987; 153: 249.
40. Yousem SA, Suncan SR, Ohori NP, et al. Architectural remodeling of lung allografts in acute and chronic rejection. Arch Pathol Lab Med 1992; 116: 1175.
41. Siddiqui MT, Garrity ER, Martinez R, et al. Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: A retrospective study of serial transbronchial biopsies with immunohistochemistry [corrected]. Mod Pathol 1996; 9: 320.
42. Law L, Zheng L, Orsida B, et al. Early changes in basement membrane thickness in airway walls post-lung transplantation. J Heart Lung Transplant 2005; 24: 1571.
43. Ward C, De SA, Fisher AJ, et al. A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. J Heart Lung Transplant 2005; 24: 533.
44. Nuesslein TG, Teig N, Rieger CH. Pulmonary haemosiderosis in infants and children. Paediatr Respir Rev 2006; 7: 45.
45. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16: 911.
46. Martinu T, Howell DN, Davis RD, et al. Pathologic correlates of bron-chiolitis obliterans syndrome in pulmonary retransplant recipients. Chest 2006; 129: 1016.
47. Pakhale SS, Hadjiliadis D, Howell DN, et al. Upper lobe fibrosis: A novel manifestation of chronic allograft dysfunction in lung transplantation. J Heart Lung Transplant 2005; 24: 1260.
48. Garaizar J, Rementeria A, Porwollik S. DNA microarray technology: A new tool for the epidemiological typing of bacterial pathogens? FEMS Immunol Med Microbiol 2006; 47: 178.